🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Linglong Deng

Wuhan University

ORCID: 0000-0003-1440-4113

Also affiliated with Zhongnan Hospital of Wuhan University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo”.

Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo

Acta Pharmaceutica Sinica B(2021)10.1016/j.apsb.2021.07.027

N/A

0DataRank · unranked

22 citations

Hannah Petrek, Mei‐Juan Tu, Neelu Batra, Aixi Yu, Ai‐Ming Yu +1 more

Fully‐humanized bioengineered miR‐1291 modulates key nutrient transport and metabolism to exert synergistic anticancer effects with chemotherapeutics

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02585

N/A

0DataRank · unranked

1 citations

Zhenzhen Liu, Linglong Deng, Chao Zhang, Ai‐Ming Yu, Mei‐Juan Tu

MiR‐124‐3p signaling in the control of metastasis‐related cytoskeleton organization, cell junctions and adhesion

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02586

N/A

0DataRank · unranked

0 citations

Hannah Petrek, Mei‐Juan Tu, Ai‐Ming Yu, Linglong Deng